Xencor (XNCR) Total Current Liabilities (2013 - 2026)

Xencor's (XNCR) quarterly Total Current Liabilities came in at $73.5 million in Q1 2026, down 16.94% year-on-year from $88.4 million in Q1 2025, and down 23.41% on a QoQ basis from $95.9 million in Q4 2025.

Xencor (XNCR) Total Current Liabilities (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Total Current Liabilities data on file, last reported at $73.5 million in Q1 2026.

  • On a quarterly basis, Total Current Liabilities fell 16.94% year-over-year to $73.5 million in Q1 2026; TTM through Mar 2026 was $73.5 million, a 16.94% decrease from a year earlier, with the FY2025 full-year figure at $95.9 million, up 9.69% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $73.5 million, down from $95.9 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for XNCR reached as high as $96.1 million in Q2 2025 and fell as low as $44.6 million in Q2 2023.
  • Historically, Total Current Liabilities has averaged $76.0 million across 5 years, with a median of $75.0 million in 2022.
  • Across the five-year window, Total Current Liabilities jumped 103.15% in 2022 and plunged 41.09% in 2023, its largest moves.
  • Year by year, Total Current Liabilities stood at $63.8 million in 2022, then grew by 15.77% to $73.9 million in 2023, then grew by 18.29% to $87.4 million in 2024, then grew by 9.69% to $95.9 million in 2025, then fell by 23.41% to $73.5 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $73.5 million in Q1 2026, $95.9 million in Q4 2025, and $86.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Xencor 1.47 Bn 1.09 Bn - 73.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 73.46 Mn
Dec 31, 2025 95.91 Mn
Sep 30, 2025 86.49 Mn
Jun 30, 2025 96.08 Mn
Mar 31, 2025 88.44 Mn
Dec 31, 2024 87.43 Mn
Sep 30, 2024 90.81 Mn
Jun 30, 2024 75.59 Mn
Mar 31, 2024 71.08 Mn
Dec 31, 2023 73.92 Mn
Sep 30, 2023 53.04 Mn
Jun 30, 2023 44.63 Mn
Mar 31, 2023 65.06 Mn
Dec 31, 2022 63.84 Mn
Sep 30, 2022 90.03 Mn
Jun 30, 2022 75.04 Mn
Mar 31, 2022 60.94 Mn
Dec 31, 2021 70.74 Mn
Sep 30, 2021 44.32 Mn
Jun 30, 2021 45.96 Mn